Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
AGO2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RAB35 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMAD5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TPT1-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ZDHHC5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GNAS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF5A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
PDE4A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PGP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COX20 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AP1S1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PVR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
JAM3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBM19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STOML1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BNIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on